-
Jazz Pharmaceuticals (JAZZ) PT Lowered to $184 at RBC Capital
-
Jazz Pharmaceuticals (JAZZ): Mixed 3Q, PT To $195 - RBC
-
RBC Capital Starts Jazz Pharmaceuticals (JAZZ) at Outperform
-
Notable Mergers and Acquisitions 5/31: (GXP)/(WR) (JAZZ)/(CPXX) (SQI) (MKTO)
-
Jazz Pharma (JAZZ) Confirms Agreement to Acquire Celator Pharma (CPXX) for $30.25/Share, or ~$1.5B
-
Jazz Pharmaceuticals And Celator Pharmaceuticals Announce Agreement For Jazz Pharmaceuticals To Acquire Celator For $30.25 Per Share
-
Pre-Open Stock Movers 2/26: (ANIK) (LJPC) (PLUG) Higher; (FST) (SEAC) (FSLR) Lower (more...)
-
Pre-Open Stock Movers 8/7: (PXLW) (MCHX) (FNSR) Higher; (NSPH) (YRCW) (FSLR) Lower (more...)
-
Notable Analyst Rating Changes 09/18: (BRCM) (GM) (OCZ) Upgraded; (RIMM) (INTC) (BBBY) Downgraded
-
Notable 52-Week Highs and Lows of the Day 08/01: (MPEL) (JAZZ) (CROX) High; (SUNH) (TEVA) (HCA) Low